Cargando…
Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases
Patients with unresectable hepatic metastases, from uveal or ocular melanoma, are challenging to treat with an overall poor prognosis. Although over the past decade significant advances in systemic therapies have been made, metastatic disease to the liver, especially from uveal melanoma, continues t...
Autores principales: | Carr, Michael J., Sun, James, Cohen, Jonathan B., Liu, Jinhong, Serdiuk, Andrew A., Stewart, Stephen R., Doobay, Navin, Duclos, Andrew, Seal, David A., Choi, Junsung, Zager, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480350/ https://www.ncbi.nlm.nih.gov/pubmed/33372814 http://dx.doi.org/10.1177/1073274820983019 |
Ejemplares similares
-
Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease
por: Karydis, Ioannis, et al.
Publicado: (2017) -
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma
por: Meijer, T. Susanna, et al.
Publicado: (2020) -
Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer
por: Meijer, T. Susanna, et al.
Publicado: (2022) -
Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies
por: Burgmans, Mark C., et al.
Publicado: (2015) -
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study
por: Meijer, T. Susanna, et al.
Publicado: (2020)